CLINICAL_TRIALS
trial_result
· 2017-12-08
Clinical Trial Update: BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial comparing BI 695501 to adalimumab in active rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Arthritis, Rheumatoid | Phase 3 | Status: COMPLETED | Results posted: 2017-12-08